Mitesco (MITI) Asset Writedowns and Impairment (2020 - 2025)
Mitesco (MITI) reported Asset Writedowns and Impairment of $86670.0 for Q4 2025, up 1142.4% on a QoQ basis from $6976.0 in Q3 2025.
Mitesco (MITI) has 3 years of Asset Writedowns and Impairment data on file, last reported at $86670.0 in Q4 2025.
- Quarterly Asset Writedowns and Impairment changed N/A year-over-year to $86670.0 in Q4 2025, while the trailing twelve-month figure through Mar 2026 was $103334.0 (up 966.73% YoY) and the FY2025 annual result came in at $113021.0, changed N/A from the prior year.
- Asset Writedowns and Impairment climbed to $86670.0 in Q4 2025 per MITI's latest filing, from $6976.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $86670.0 in Q4 2025 and bottomed at $6976.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Veeva Systems | 30.85 Bn | 24.28 Bn | 622.47 Mn |
| 2 | BrightSpring Health Services | 12.29 Bn | 11.41 Bn | 482.22 Mn |
| 3 | Healthequity | 7.80 Bn | 7.48 Bn | 256.31 Mn |
| 4 | Hinge Health | 4.82 Bn | 4.51 Bn | 154.23 Mn |
| 5 | Doximity | 4.21 Bn | 3.46 Bn | 125.97 Mn |
| 6 | Waystar Holding | 4.18 Bn | 4.03 Bn | 268.04 Mn |
| 7 | 10x Genomics | 3.78 Bn | 3.24 Bn | 106.18 Mn |
| 8 | Privia Health | 2.65 Bn | 2.28 Bn | 595.71 Mn |
| 9 | Omnicell | 1.95 Bn | 1.78 Bn | 140.36 Mn |
| 10 | Mitesco | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -17,651.00 |
| Dec 31, 2025 | -17,651.00 |
| Sep 30, 2025 | 6,976.00 |
| Sep 30, 2025 | 6,976.00 |
| Jun 30, 2025 | 9,688.00 |
| Jun 30, 2025 | 9,688.00 |
| Mar 31, 2025 | 9,687.00 |
| Mar 31, 2025 | 9,687.00 |
| Jun 30, 2023 | 48,190.00 |
| Jun 30, 2023 | 48,190.00 |
| Mar 31, 2023 | 83,810.00 |
| Mar 31, 2023 | 83,810.00 |
| Mar 31, 2020 | 71,558.00 |
| Mar 31, 2020 | 71,558.00 |